Intelomed, Inc.

CIK: 1482781DEIncorporated: 2005-02-24

Current Offering

$10,000
Target Amount
$1,069,999
Maximum Amount
2023-01-09
Deadline

Security Details

Type: Series C Preferred Stock
Price per share: $1.20
Shares offered: 8,333+

Offering Costs

Cash commission: 9%
up to 9% percent
Equity compensation: 3%
Three percent (3%) of securities of the total amount of investments raised in the offering, along the same terms as investors.

Financial Reports

Offering via StartEngine

Offering History

As of 2022-10-11
Raising $10,000 -$1,069,999 via 8,333+ shares of series C Preferred Stock at $1.20 per share
Deadline: 2023-01-09
Filing date2022-10-11
Current employees3
Act received most recent fiscal year$14,760
Act received prior fiscal year$3,440
Cash equi most recent fiscal year$267,374
Cash equi prior fiscal year$738,197
Cost goods sold most recent fiscal year$3,752
Cost goods sold prior fiscal year$70.00
Long term debt most recent fiscal year$5,334,624
Long term debt prior fiscal year$4,552,082
Net income most recent fiscal year-$1,266,444.88
Net income prior fiscal year-$1,265,112.04
Revenue most recent fiscal year$33,203
Revenue prior fiscal year$14,150
Short term debt most recent fiscal year$108,150
Short term debt prior fiscal year$102,511
Tax paid most recent fiscal year$0.00
Tax paid prior fiscal year$0.00
Total asset most recent fiscal year$513,556
Total asset prior fiscal year$991,820

Company Information

Corporation
DE
2005-02-24

Latest Metrics

Employees3
Total Assets$513,556
Cash on Hand$267,374
Revenues$33,203
Net Income-$1,266,444.88

Crowdfunding Portals

This company is raising funds through this portal